… prophylactic pancreatic-stent placement to reduce the risk of pancreatitis, … , transdermal
GTN did not improve the rate of success in ERCP cannulation or prevent post-ERCP pancreatitis …

… -designed placebo-controlled RCTs are needed to confirm the effect of … A prospective,
randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical …

… a protective effect of GTN against post-ERCP pancreatitis, we … of GTN before ERCP. As
described above, two … Transdermal administration of glyceryl trinitrate achieves the same …

… the ERCP… post-ERCP pancreatitis, 12 we found that transdermal GTN was ineffective. The
possible reasons could be lack of a true effect, suboptimal dosing, or a small therapeutic effect …

… In a randomized double-blind placebo-controlled trial of 806 … Acute pancreatitis after ERCP
is a complication we want to … relaxant effect on the sphincter of Oddi because transdermal GN …

… in post-ERCP pancreatitis) was observed after ERCP (3/21 cases of post-ERCP pancreatitis
… , it would be necessary to study 128 patients to confirm a reduction in post-ERCP AP, with a …

… and observed the preventive effect of glycery trinitrate on post-ERCP pancreatitis. … study
showed that glyceryl trinitrate could relax the sphincter of pancreatic and bile ducts when ERCP …

… endoscopic retrograde cholangiopancreatography (ERCP) [1] . The incidence of post-ERCP
pancreatitis … The four routes of GTN used in the trials were topical, sublingual, transdermal, …

… endoscopic retrograde cholangiopancreatography (ERCP). Because of the potential risks and
consequences of post-ERCP pancreatitis, … placebo-controlled randomized clinical trial. Am …

… endoscopic retrograde cholangiopancreatography (ERCP). Because of the potential risks and
consequences of post-ERCP pancreatitis, … placebo-controlled randomized clinical trial. Am …